Glucose lowering treatments and cardiovascular risk

被引：0
|
作者：
Bonnet, F. [1 ]
机构：
[1] Hop Sud, Serv Endocrinol Diabetol Nutr, Rennes, France
来源：
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION | 2010年 / 14卷 / 09期
关键词：
Cardiovascular; Glucose lowering treatment; Diabetes; MYOCARDIAL-INFARCTION; MORTALITY; OUTCOMES; SULFONYLUREAS; PIOGLITAZONE; DISEASE; TRIAL;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：281 / 284
页数：4
相关论文
共 50 条
  • [41] New glucose-lowering drugs for reducing cardiovascular risk in patients with type 2 diabetes mellitus
    Gorgojo-Martinez, J. J.
    HIPERTENSION Y RIESGO VASCULAR, 2019, 36 (03): : 145 - 161
  • [42] Lowering the threshold for impaired fasting glucose: Impact on disease prevalence and associated risk of diabetes and cardiovascular disease
    Vaccaro, O
    Di Bonito, P
    Masulli, M
    Galasso, R
    Riccardi, G
    DIABETES, 2005, 54 : A261 - A261
  • [43] Perspectives on Some Controversies in Cardiovascular Disease Risk Assessment in the Pharmaceutical Development of Glucose-Lowering Medications
    Hoogwerf, Byron J.
    Manner, David H.
    Fu, Haoda
    Moscarelli, Elena
    Gaydos, Brenda L.
    Heine, Robert J.
    DIABETES CARE, 2016, 39 : S219 - S227
  • [44] Newer Glucose-Lowering Drugs and Risk of Dementia: A Meta-analysis of Cardiovascular Outcome Trials
    Tang, Huilin
    Niu, Shu
    Brown, Joshua D.
    Wei, Jingkai
    Winterstein, Almut G.
    Bian, Jiang
    Guo, Jingchuan
    DIABETES, 2022, 71
  • [45] Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
    Van Regemorter, Elliott
    Jadoul, Michel
    Gillion, Valentine A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (10): : 954 - 955
  • [46] Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
    Das Pradhan, Aruna
    Glynn, Robert J.
    Fruchart, Jean-Charles
    MacFadyen, Jean G.
    Zaharris, Elaine S.
    Everett, Brendan M.
    Campbell, Stuart E.
    Oshima, Ryu
    Amarenco, Pierre
    Blom, Dirk J.
    Brinton, Eliot A.
    Eckel, Robert H.
    Elam, Marshall B.
    Felicio, Joao S.
    Ginsberg, Henry N.
    Goudev, Assen
    Ishibashi, Shun
    Joseph, Jacob
    Kodama, Tatsuhiko
    Koenig, Wolfgang
    Leiter, Lawrence A.
    Lorenzatti, Alberto J.
    Mankovsky, Boris
    Marx, Nikolaus
    Nordestgaard, Borge G.
    Pall, Denes
    Ray, Kausik K.
    Santos, Raul D.
    Soran, Handrean
    Susekov, Andrey
    Tendera, Michal
    Yokote, Koutaro
    Paynter, Nina P.
    Buring, Julie E.
    Libby, Peter
    Ridker, Paul M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (21): : 1923 - 1934
  • [47] Newer glucose-lowering drugs and risk of dementia: A meta-analysis of cardiovascular outcome trials
    Tang, Huilin
    Niu, Shu
    Brown, Joshua
    Wei, Jingkai
    Shao, Hui
    Bian, Jiang
    Guo, Jingchuan
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2022, 70 (09) : 2719 - 2722
  • [48] Lowering blood pressure for cardiovascular risk reduction
    McInnes, GT
    JOURNAL OF HYPERTENSION, 2005, 23 : S3 - S8
  • [49] RA-lowering cardiovascular risk with statins
    Lee, Justin M. S.
    Choudhury, Robin P.
    NATURE REVIEWS RHEUMATOLOGY, 2010, 6 (03) : 123 - 124
  • [50] Does lowering triglycerides reduce cardiovascular risk?
    de Moura, Jose Pereira
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2019, 38 (08) : 543 - 545
12345